BELLICUM PHARMACEUTICALS CEO Richard Fair's 2020 pay jumps 55% to $2.7M
BELLICUM PHARMACEUTICALS reports 2020 executive compensation
By ExecPay News
Published: April 29, 2021
BELLICUM PHARMACEUTICALS reported fiscal year 2020 executive compensation information on April 29, 2021.
In 2020, three executives at BELLICUM PHARMACEUTICALS received on average a compensation package of $2M, a 85% increase compared to previous year.
Average pay of disclosed executives at BELLICUM PHARMACEUTICALS
Richard A. Fair, Chief Executive Officer, received $2.7M in total, which increased by 55% compared to 2019. 67% of Fair's compensation, or $1.8M, was in option awards. Fair also received $249K in non-equity incentive plan, $626K in salary, as well as $21K in other compensation.
Atabak Mokari, Chief Financial Officer, received a compensation package of $1.7M, which increased by 49% compared to previous year. 33% of the compensation package, or $543K, was in option awards.
Shane M. Ward, Secretary, earned $1.5M in 2020, a 153% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2021.